Literature DB >> 4146584

Plasma half-lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man.

D S Hewick, J McEwen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4146584     DOI: 10.1111/j.2042-7158.1973.tb09133.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  28 in total

1.  Species-dependent stereospecific serum protein binding of the oral anticoagulant drug phenprocoumon.

Authors:  W Schmidt; E Jähnchen
Journal:  Experientia       Date:  1978-10-15

Review 2.  Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure.

Authors:  Andrea Lee; Mark Crowther
Journal:  J Thromb Thrombolysis       Date:  2011-04       Impact factor: 2.300

Review 3.  Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.

Authors:  Mike Ufer
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

4.  Age as a determinant of sensitivity to warfarin.

Authors:  A M Shepherd; D S Hewick; T A Moreland; I H Stevenson
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

5.  Interaction of clofibrate with warfarin. I. Effect of clofibrate on the disposition of the optical enantiomorphs of warfarin.

Authors:  T D Bjornsson; P J Meffin; T F Blaschke
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

6.  Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.

Authors:  R J Lewis; W F Trager; K K Chan; A Breckenridge; M Orme; M Roland; W Schary
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

Review 7.  Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.

Authors:  D E Drayer
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

8.  The measurement of warfarin enantiomers in serum using coupled achiral/chiral, high-performance liquid chromatography (HPLC).

Authors:  Y Q Chu; I W Wainer
Journal:  Pharm Res       Date:  1988-10       Impact factor: 4.200

Review 9.  Pharmacogenetics of oral anticoagulants: a basis for dose individualization.

Authors:  Simone Stehle; Julia Kirchheiner; Andreas Lazar; Uwe Fuhr
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

10.  Microbial transformations of warfarin: stereoselective reduction by Nocardia corallina and Arthrobacter species.

Authors:  P J Davis; J D Rizzo
Journal:  Appl Environ Microbiol       Date:  1982-04       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.